Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Lymph Node Dissection in the Management of High-risk Primary Upper Tract Urothelial Carcinoma Patients

NCT03230201 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT03230201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Lymph Node Dissection in the Management of High-risk Primary Upper Tract Urothelial Carcinoma Patients
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2017
Completion date
January 1, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node dissection, metastasis, recurrence, upper tract urothelial carcinoma